Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons (Q28568370)

https://api.crossref.org/works/10.1002%2FGLIA.20185

Hyperhomocysteinemia as an independent risk factor for silent brain infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

Characterization of the stress-inducing effects of homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

Homocysteine-induced changes in mRNA levels of genes coding for cytoplasmic- and endoplasmic reticulum-resident stress proteins in neuronal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Glutamate-induced homocysteic acid release from astrocytes: possible implication in glia-neuron signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Elevated levels of plasma homocysteine are associated with neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine and brain atrophy on MRI of non-demented elderly

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

beta-Adrenergic stimulation promotes homocysteic acid release from astrocyte cultures: evidence for a role of astrocytes in the modulation of synaptic transmission.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine uptake by human umbilical vein endothelial cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Simultaneous measurement by HPLC of the excitatory amino acid transmitter candidates homocysteate and homocysteine sulphinate supports a predominant astrocytic localisation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Molecular basis of homocysteine toxicity in humans.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Neuronal and non-neuronal catechol-O-methyltransferase in primary cultures of rat brain cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Cystathionine synthase in rat brain: Regional and time-of-day differences and their metabolic implications

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine induces cell death of rat astrocytes in vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

In vivo and in vitro effects of homocysteine on Na+, K+-ATPase activity in parietal, prefrontal and cingulate cortex of young rats.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

3-OMD and homocysteine plasma levels in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine and Folate Deficiency Sensitize Oligodendrocytes to the Cell Death-Promoting Effects of a Presenilin-1 Mutation and Amyloid β-Peptide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Optimization of serum-free culture conditions for growth of embryonic rat cholinergic basal forebrain neurons.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

The neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Identification and characterization of uptake systems for cystine and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Homocysteate and homocysteine sulfinate, excitatory transmitter candidates present in rat astroglial cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Kinetics of rat brain soluble catechol-O-methyltransferase and its inhibition by substrate analogues

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021

Levodopa-induced hyperhomocysteinaemia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20185

7 January 2021